Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 475

2.
5.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group..

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
6.

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group..

Diabet Med. 2000 Nov;17(11):762-70.

PMID:
11131100
7.

Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.

Stades AM, Hoekstra JB, van den Tweel I, Erkelens DW, Holleman F; STABILITY Study Group..

Diabetes Care. 2002 Apr;25(4):712-7.

PMID:
11919130
8.

Treatment of type 1 diabetes with insulin lispro during Ramadan.

Kadiri A, Al-Nakhi A, El-Ghazali S, Jabbar A, Al Arouj M, Akram J, Wyatt J, Assem A, Ristic S.

Diabetes Metab. 2001 Sep;27(4 Pt 1):482-6.

PMID:
11547222
9.
10.
11.

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

Malone JK, Bai S, Campaigne BN, Reviriego J, Augendre-Ferrante B.

Diabet Med. 2005 Apr;22(4):374-81.

PMID:
15787659
14.

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

Pfützner A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J.

Exp Clin Endocrinol Diabetes. 1996;104(1):25-30.

PMID:
8750567
15.

Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.

Colombel A, Murat A, Krempf M, Kuchly-Anton B, Charbonnel B.

Diabet Med. 1999 Apr;16(4):319-24.

PMID:
10220206
16.
17.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
18.

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.

Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB.

Diabet Med. 1998 Jul;15(7):592-600.

PMID:
9686700
19.

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

Holcombe JH, Zalani S, Arora VK, Mast CJ; Lispro in Adolescents Study Group..

Clin Ther. 2002 Apr;24(4):629-38.

PMID:
12017407
20.

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.

Heller SR, Colagiuri S, Vaaler S, Wolffenbuttel BH, Koelendorf K, Friberg HH, Windfeld K, Lindholm A.

Diabet Med. 2004 Jul;21(7):769-75.

PMID:
15209772

Supplemental Content

Support Center